Compass Biotechnologies, Inc. (PINK:COBI) is a bio-pharmaceutical company which doesn’t have much to boast about, but it may see some action today, after being promoted.
Yesterday, COBI closed up 10% at $0.022 per share with the volume reaching 289 thousand shares.
COBI is late in filing its 10-Q for the quarter ended October 31, 2011 and its previous quarterly was not particularly encouraging, but someone saw fit to pay $5 thousand for a two-day promotional campaign of COBI.
The company increased its authorized shares in December, and ever since there has been little news about its affairs.[BANNER]
COBI did announce it was relocating its headquarters from Alberta, Canada to Phoenix, Arizona about a week ago, but not much is clear about their current financial state and operations.
The promotion could spark some interest, and there is still time for news before the open. Still, while the promotional mail says COBI is “targeting huge markets for growth,” there is absolutely no guarantee it will get anywhere.
